Concepedia

Author

Simone Leyden

Peter MacCallum Cancer CentreORCID

Also Known As

S. Leyden, Simone Leyden

29

Publications

260

Citations

7

H-Index

23

Concepts

All Affiliations

Peter MacCallum Cancer CentreThe University of SydneyRoyal North Shore HospitalMonash UniversityNorthern Cancer Institute
SL

About

Simone Leyden is an author at Peter MacCallum Cancer Centre specializing in oncology, cancer research, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

96

2

Pathology

3

3

78

3

Pharmacology

3

3

78

4

Health Sciences

2

2

54

5

Gastroenterology

2

2

54

Simone Leyden

×

5

Publications

126

Citations

5

H-Index

YearCitations

Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals

Simone Leyden, Teodora Kolarova, Catherine Bouvier,

International Journal of Cancer

2019

30

Australasian Gastrointestinal Trials Group (AGITG) CONTROL NET Study: <sup>177</sup>Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) and capecitabine plus temozolomide (CAPTEM) for pancreas and midgut neuroendocrine tumours (pNETS, mNETS)—Final results.

Nick Pavlakis, David Ransom, David Wyld,

Journal of Clinical Oncology

2022

28

Australasian Gastrointestinal Trials Group (AGITG) CONTROL NET Study: Phase II study evaluating the activity of <sup>177</sup>Lu-Octreotate peptide receptor radionuclide therapy (LuTate PRRT) and capecitabine, temozolomide CAPTEM)—First results for pancreas and updated midgut neuroendocrine tumors (pNETS, mNETS).

Nick Pavlakis, David Ransom, David Wyld,

Journal of Clinical Oncology

2020

26

Pivotal phase III COMPOSE trial will compare <sup>177</sup>Lu-edotreotide with best standard of care for well-differentiated aggressive grade 2 and grade 3 gastroenteropancreatic neuroendocrine tumors.

Diane Reidy‐Lagunes, Namrata Vijayvergia, Daniel M. Halperin,

Journal of Clinical Oncology

2022

24

The Economic Impact on Australian Patients with Neuroendocrine Tumours

Louisa G. Gordon, Thomas M. Elliott, Kate Wakelin,

Patient

2020

18

Page 1